AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

By Sidney C. Smith, Jerilyn K. Allen, S. Blair, R. Bonow, L. Brass, G. Fonarow, S. Grundy, L. Hiratzka, Daniel W. Jones, Harlan M. Krumholz and 4 more. Circulation, 2006

2,200 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Radiology, Nuclear Medicine and Imaging, Surgery

View Paper: https://www.semanticscholar.org/paper/ff24b91e38d404dffddd3d0ce59bd328b9d39834

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. Harlan M. Krumholz
2. S. Daniels
3. M. S. Kirkman
4. A. Classification
5. R. Bilous

In Radiology, Nuclear Medicine and Imaging

1. M. Creager
2. A. Classification

In Surgery

1. Silvio E. Inzucchi
2. I. Hirsch
3. M. S. Kirkman
4. Judith Hochman
5. S. Gidding
6. M. Creager
7. A. Classification
8. R. Bilous

Citations in the corpus

• Guidelines on myocardial revascularization. (2010, background): “programme after revascularization [265].”
• Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease (2010, background): “Recommendations for statins are noted for other manifestations of atherosclerotic diseases (409) (see Section 9.”
• Standards of Medical Care in Diabetes—2008 (2008, background): “Aspirin has been recommended for primary (177,178) and secondary (179,180) prevent ion of cardiovascular events in high-risk diabetic and nondiabetic individuals.”
• 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008, neutral): “Sabatine MS et al. (9); Bennett JS et al. (10); Smith SC Jr et al. ( 11 ); OAT (12,13) and TOSCA (14)].”